金融界6月9日消息，周一港股集体高开，盘面上，大型科技股、医药股多数走高，截至11：30，港股科 技50ETF(513980)涨1.69%，成交额达5.07亿元。盘中最高涨超2%，年内至今已涨超32%！ 热门个股方面，创新药概念股活跃，金斯瑞生物科技涨超14%，三生制药涨超7%，信达生物等涨超 6%，快手-W等涨超5%，美团-W、中芯国际涨超4%，理想汽车-W涨超3%，百济神州涨超2%，阿里巴 巴-W等跟涨。 资金净流入方面来看，Wind数据统计，截至最新收盘日，港股科技50ETF(513980)近三月区间净流入额 46.87亿元，年初至今区间净流入额62.05亿元。 华泰证券指出，往前看，中美元首通话释放积极信号下关税摩擦影响或进一步减弱，出口链压力缓和下 中国增长预期或抬升，尤其是在此前并未跟随其他货币升值的情况下，人民币及人民币资产均有补涨空 间，短期市场风险偏好提振下我们依然看好港股相对全球市场的收益表现。 兴业证券表示，6月市场主线有望再度偏向科技成长。近期，已观察到成长板块已自底部"蠢蠢欲动"。 当前从拥挤度、滚动收益差、成交占比、日历效应等各项指标来看，近期科技板块的位置已自底部抬 升，整体仍处 ...

看好港股科技发展前景，不妨关注港股科技50ETF(513980)及其联接基金（A类：016495；C类： 016496），助力布局港股优质资产赛道。 来源：金融界 金融界5月6日消息，周二开盘港股迎来五月假期后"开门红"，三大指数集体走强，盘面上，DeepSeek及 黄金概念股普涨，截至10：35，港股科技50ETF(513980)涨2.33%。 消息面上，近期港币汇率持续走强，逼近 7.75 的联系汇率上限，香港金融管理局（HKMA）多次干预 以平衡汇率，背后或折射出国际资本对港股资产的强烈配置需求。在香港房地产市场仍处调整期的背景 下，资金集中流向港股科技及互联网板块的趋势显著。 根据国泰海通证券统计，2024年港股净利润增速继续回升。2024年全部港股归母净利润累计同比为 9.8%，其中，上半年/下半年同比分别为7.5%/13.3%，下半年港股净利润增速大幅上行。该机构认为， 展望未来，尽管外部环境或有阶段性扰动，但国内政策发力背景下经济望维持韧性，叠加科技周期回 升，预计港股盈利增速维持高位。 截至最新，港股科技50ETF（513980）基金规模144亿元，在跟踪同指数ETF基金中规模第一！港股科 技 ...

Core Viewpoint - The Hong Kong stock market is gradually stabilizing and rebounding as the impact of tariffs diminishes, with significant gains in major indices, particularly in technology and consumer sectors [1][2]. Group 1: Market Performance - As of April 23, the Hang Seng Technology Index rose by 2.84%, the Hang Seng Index by 2.11%, and the Hang Seng China Enterprises Index by 1.83% [1]. - Since March 20, the Hong Kong stock market has experienced continuous adjustments, but has begun to recover due to interventions from state-owned enterprises [2]. Group 2: Investment Opportunities - The Hong Kong stock market is seeing a growing proportion of technology and new consumer companies, which are expected to account for 54.5% of the total market capitalization by the end of 2024 [2]. - ETFs focusing on technology, consumption, and innovative pharmaceuticals are becoming popular among investors, providing efficient access to these sectors [1][3]. Group 3: Specific ETF Products - The Hong Kong Technology 50 ETF (513980) targets large-cap technology leaders with high R&D investment and revenue growth, including companies like Meituan and Tencent [2]. - The Hang Seng Consumption ETF (513970) focuses on essential and discretionary consumer goods, excluding alcohol and internet platforms, aiming to capture opportunities in consumer recovery [3]. - The Hong Kong Innovative Drug 50 ETF (513780) tracks leading companies in the innovative pharmaceutical sector, which is relatively scarce compared to the A-share market [3].